News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Rafael Fonseca: AI to the Rescue for IMS Abstract Highlights
Rafael Fonseca/X
Aug 30, 2025, 22:08

Rafael Fonseca: AI to the Rescue for IMS Abstract Highlights

Rafael Fonseca, Chief Innovation Officer and Professor of Medicine at Mayo Clinic, shared a post on X:

“AI to the rescue. An Excel sheet with the conclusions of the abstracts being presented at the International Myeloma Society (IMS) meeting in Toronto (some mistakes, but overall OK).”

More posts featuring Rafael Fonseca.

cancer International Myeloma Society International Myeloma Society meeting MM Myeloma OncoDaily Oncology Rafael Fonseca
Special Coverage
Voices
Aug 30, 2025, 22:08
Rafael Fonseca: AI to the Rescue for IMS Abstract Highlights
Insight
Aug 30, 2025, 22:08
George Kumar: Exploring Autologous TIL Therapy in Recurrent/Metastatic HNSCC
Science
Aug 30, 2025, 22:01
Richard White: What Triggers Changes in Cancer Cell State?
Voices
Aug 30, 2025, 21:57
Gavitt Woodard Congratulates Team on Study of Biomarker Testing in 2024 Global Survey
Voices
Aug 30, 2025, 21:51
Komal Jhaveri: OS Benefit with Adjuvant Abemaciclib in MonarchE Trial
Societies
Aug 30, 2025, 21:48
Updated ESMO Clinical Practice Guideline on Early and Locally Advanced NSCLC
Societies
Aug 30, 2025, 21:47
Welcoming Judson Brewer as Keynote Speaker at SIO 2025
Societies
Aug 30, 2025, 21:46
Gina Brown Joins as Keynote on Colorectal Cancer Imaging at EIOC 2025
Science
Aug 30, 2025, 21:45
Alireza Mansouri: ACHIEVE Trial Explores Targeted Therapy for Brain Metastases in Lung Cancer
Insight
Aug 30, 2025, 21:43
Anirban Maitra Congratulates Van Morris on New Cancer Cell Study on Triple Therapy in mCRC
Science
Aug 30, 2025, 21:43
MD Anderson Cancer Center Awarded Over $9M SPORE Grant for Sarcoma Research
Societies
Aug 30, 2025, 21:41
New Kenyan Network of Cancer Organizations Board Outlines Vision for the Next 3 Years